CRCA vs. SCUS

Last updated Jun 25, 2026

CRCA (ProShares Ultra CRCL) and SCUS (Schwab Ultra-Short Income ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while SCUS is a Ultrashort Bond fund actively managed by Charles Schwab. Both are actively managed. At a correlation of -0.09, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.14%/yr for SCUS.

Performance

CRCA vs. SCUS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra CRCL (CRCA) and Schwab Ultra-Short Income ETF (SCUS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRCA achieves a -56.81% return, which is significantly lower than SCUS's 1.57% return.

CRCA

• 1D: -13.29%
• 1M: -64.42%
• YTD: -56.81%
• 6M: -60.16%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SCUS

• 1D: 0.06%
• 1M: 0.26%
• YTD: 1.57%
• 6M: 1.61%
• 1Y: 4.03%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRCA vs. SCUS - Yearly Performance Comparison

	2026 (YTD)	2025
CRCA ProShares Ultra CRCL	-56.81%	-84.67%
SCUS Schwab Ultra-Short Income ETF	1.57%	1.76%

Correlation

The correlation between CRCA and SCUS is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025	-0.09

Return for Risk

CRCA vs. SCUS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRCA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

SCUS

SCUS Risk / Return Rank: 99
SCUS Sharpe Ratio Rank: 99
SCUS Sortino Ratio Rank: 99
SCUS Omega Ratio Rank: 99
SCUS Calmar Ratio Rank: 99
SCUS Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRCA vs. SCUS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Schwab Ultra-Short Income ETF (SCUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRCA	SCUS	Difference
Sharpe ratio: Return per unit of total volatility	—	5.97	—
Sortino ratio: Return per unit of downside risk	—	11.48	—
Omega ratio: Gain probability vs. loss probability	—	2.61	—
Calmar ratio: Return relative to maximum drawdown	—	24.25	—
Martin ratio: Return relative to average drawdown	—	104.79	—

Drawdowns

CRCA vs. SCUS - Drawdown Comparison

The maximum CRCA drawdown since its inception was -94.31%, which is greater than SCUS's maximum drawdown of -0.17%. Use the drawdown chart below to compare losses from any high point for CRCA and SCUS.

Drawdown Indicators

	CRCA	SCUS	Difference
Max Drawdown Largest peak-to-trough decline	-94.31%	-0.17%	-94.14%
Max Drawdown (1Y) Largest decline over 1 year	—	-0.17%	—
Current Drawdown Current decline from peak	-93.38%	0.00%	-93.38%
Average Drawdown Average peak-to-trough decline	-71.83%	-0.02%	-71.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.04%	—

Volatility

Volatility by Period

	CRCA	SCUS	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	0.23%	—
Volatility (6M) Calculated over the trailing 6-month period	—	0.50%	—
Volatility (1Y) Calculated over the trailing 1-year period	194.72%	0.68%	+194.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	194.72%	0.71%	+194.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	194.72%	0.71%	+194.01%

CRCA vs. SCUS - Expense Ratio Comparison

CRCA has a 0.95% expense ratio, which is higher than SCUS's 0.14% expense ratio.

Dividends

CRCA vs. SCUS - Dividend Comparison

CRCA's dividend yield for the trailing twelve months is around 4.01%, more than SCUS's 3.91% yield.

Position	TTM	2025	2024
CRCA ProShares Ultra CRCL	4.01%	1.06%	0.00%
SCUS Schwab Ultra-Short Income ETF	3.91%	4.17%	1.62%

Frequently Asked Questions

Can I hold both CRCA and SCUS in my portfolio?

CRCA and SCUS have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CRCA or SCUS?

On fees, SCUS is cheaper at 0.14% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CRCA or SCUS?

SCUS is cheaper with a 0.14% expense ratio, compared with 0.95% for CRCA.

Which ETF pays a higher dividend yield, CRCA or SCUS?

CRCA has the higher dividend yield at 4.01%, compared with 3.91% for SCUS.

What is the main difference between CRCA and SCUS?

CRCA is categorized as Leveraged Equities, while SCUS is Ultrashort Bond. They also come from different issuers: ProShares and Charles Schwab. Their fees differ too: 0.95% for CRCA and 0.14% for SCUS.